NCT00159016View on ClinicalTrials.gov

Role of Glivec in Patients With Tumor Cells Positive for C-kit or PDGFR; a Multi Center Study.

PHASE2WithdrawnINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

August 31, 2002

Study Completion Date

September 30, 2005

Conditions

Metastatic Solid Tumors.

Interventions

DRUG

Glivec

Trial Locations (1)

91120

Hadassah Medical Organization, Jerusalem

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Novartis

INDUSTRY

lead

Hadassah Medical Organization

OTHER

NCT00159016 - Role of Glivec in Patients With Tumor Cells Positive for C-kit or PDGFR; a Multi Center Study. | Biotech Hunter | Biotech Hunter